Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains

International Journal of Experimental Pathology

Volumn 91, Issue 3, 2010, Pages 288-301

  Jones, Huw Bowen ^a   Nugent, David ^a   Jenkins, Richard ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Biochemistry; Diabetes; Han Wistar rat; Insulin resistance; Islets of Langerhans; Pathology; Wistar rat; Zucker diabetic fatty rat; Zucker fatty rat

Indexed keywords

COLLAGEN; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DEATH; CELL INFILTRATION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FIBROBLAST; HISTOPATHOLOGY; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; MONONUCLEAR CELL; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; RAT; RAT STRAIN; T LYMPHOCYTE; WISTAR RAT; ZUCKER DIABETIC FATTY RAT;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, NONESTERIFIED; FRUCTOSAMINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; LACTIC ACID; OBESITY; RATS; RATS, WISTAR; RATS, ZUCKER; TRIGLYCERIDES;

EID: 77952705847     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00713.x     Document Type: Article

References (49)

1. Atef N., Ktorza A., Picon L., Penicaud L. (1992) Increased islet blood flow in obese rats: role of the autonomic nervous system. Am. J. Physiol. 262, E736 E740.
2. Atef N., Portha B., Penicaud L. (1994) Changes in islet blood flow in rats with NIDDM. Diabetologia 37, 677 680.
3. Bonner-Weir S., (2001) β-Cell turnover. Its assessment and implications. Diabetes 50, S20 24.
4. Booth G., Stalker T.J., Lefer A.M., Scalia R. (2001) Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am. J. Physiol. Endocrinol. Metab. 280, E848 E856.
5. Brownlee M. (1995) Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223 234.
6. Carlsson P.O., Jansson L., Ostenson C.G., Kallskog O. (1997) Islet capillary blood pressure increase mediated by hyperglycaemia in NIDDM GK rats. Diabetes 46, 947 952.
7. Clark J.B., Palmer C.J., Shaw W.N. (1983) The diabetic Zucker Fatty rat. Proc. Soc. Exp. Biol. Med. 173, 68 75.
8. Clark A., Wells C.A., Buley I.D. et al. (1988) Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9, 151 159.
9. Devaraj S., Venugopal S.K., Singh U., Jialal I. (2005) Hyperglycaemia induces monocytic release of interleukin-6 via induction of protein kinase c-α and -β. Diabetes 54, 85 91.
10. Donath M., Schumann D.M., Faulenbach M., Ellingsgaard H., Perren A, Ehses J.A. (2008) Islet inflammation in type 2 diabetes. Diabetes Care 31, S161 S164.
11. Donath M.Y., Boni-Schnetzler M., Ellingsgaard H., Ehses J.A (2009) Islet inflammation impairs the pancreatic β cell in type 2 diabetes. Physiology 24, 325 331.
12. Ehses J.A., Perren A., Eppler E. et al. (2007) Increased number of islet associated macrophages in type 2 diabetes. Diabetes 56, 2356 2370.
13. Ehses J.A., Ellingsgaard H., Boni-Schnetzler M., Donath M.Y. (2009) Pancreatic islet inflammation in type 2 diabetes: from α and β cell compensation to dysfunction. Arch. Physiol. Biochem. 115, 240 247.
14. Gabbiani G. (2003) The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200, 500 503.
15. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. (2007) The myofibroblast: one function, multiple origins. Am. J. Pathol. 170, 1807 1816.
16. Homo-Delarche F. Drexhage H.A. (2004) Immune cells, pancreas development, regeneration and Type 1 diabetes. Trends Immunol. 25, 222 229.
17. Homo-Delarche F., Calderari S., Irminger J.-C. et al. (2006) Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 55, 1625 1633.
18. Iwase M., Uchizono Y., Tashiro K., Goto D., Iida M. (2002) Islet hyperfusion during prediabetic phase in OLETF rats, a model of type 2 diabetes. Diabetes 51, 2530 2535.
19. Janssen S.W.J., Martens G.J.M., Sweep C.G.J.F., Ross H.A., Hermus A.R.M.M. (1999) In Zucker Diabetic Fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight. Horm. Metab. Res. 31, 610 615.
20. Janssen S.W.J., Hermus A.R.M.M., Lange W.P.H. et al. (2001) Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats. Endocrinol. Diab. 109, 273 282.
21. Janssen S.W.J., Martens G.J.M., Sweep C.G.J., Span P.N., Verhofstad A.A.J., Hermus A.R.M.M. (2003) Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats. J. Endocrinol. Invest. 26, 508 515.
22. Jansson L. Hellerstrom C. (1986) Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system. Am. J. Physiol. Endocrinol. Metab. 14, E644 E647.
23. Kloppel G., Lohr M., Habich K., Oberholzer M., Heitz P.U. (1985) Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 4, 110 125.
24. Larsen C.M., Faulenbach M., Vaag A. et al. (2007) Interleukin-1-receptor antagonist in type 2 diabetes. New Engl. J. Med. 356, 1517 1526.
25. Listenberger L.L., Xianlin H., Lewis S.E. et al. (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl Acad. Sci. USA 100, 3077 3082.
26. Masuyama T., Komeda K., Hara A. et al. (2004) Chronological characterisation of diabetes development in male Spontaneously Diabetic Torii rats. Biochem. Biophys. Res. Commun. 314, 870 877.
27. Mizuno A., Noma Y., Kumajima M, Murakami T., Zhu M., Shima K. (1999) Changes in islet capillary angioarchitecture coincide with impaired β cell function but not with insulin resistance in male Otsuka-Long-Evans-Tokushima fatty rats: dimorphism of the diabetic phenotype at an advanced age. Metabolism 48, 477 483.
28. Morigi M., Angioletti S., Imberti B. et al. (1998) Leucocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycaemia in a NF-kβ-dependent fashion. J. Clin. Invest. 101, 1905 1915.
29. Nathan C.F. (1987) Secretory products of macrophages. J. Clin. Invest. 79, 319 326.
30. Ohneda M., Inman L.R., Unger R.H. (1995) Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia 38, 173 179.
31. Osborn O., Brownell S.E., Sanchez-Alavez M., Salomon D., Gram H., Bartfai T. (2008) Treatment with an interleukin 1 beta antibody improves glycaemic control in diet induced obesity. Cytokine 44, 141 148.
32. Paris M., Bernard Kargar C., Berthault M.F., Bouwens L., Ktorza A. (2003) Specific and combined effects of insulin and glucose on functional pancreatic β cell mass in vivo in adult rats. Endocrinology 144, 2717 2727.
33. Pearse A.G.E. (1985) Histochemistry. Vol 2. Analytical Technology. Churchill Livingstone
34. Peterson R.G., Shaw W.N., Neel M.A., Little L.A., Eichenberg J. (1990) Zucker diabetic fatty rat as a model of non-insulin dependent diabetes mellitus. ILAR J. 32, 16 19.
35. Pick A., Clark J., Kubstrup C. et al. (1998) Role of apoptosis in failure of β cell mass compensation for insulin resistance and β cell defects in the male Zucker diabetic fatty rat. Diabetes 47, 358 364.
36. Poitout V. Robertson R.P. (2008) Glucolipotoxicity: fuel excess and β cell dysfunction. Endocr. Rev. 29, 351 366.
37. Rahier J., Goebbles R.M., Henquin J.C. (1983) Cellular composition of the human diabetic pancreas. Diabetologia 24, 366 371.
38. Richardson S.J., Willcox A., Bone A.J., Foulis A.K., Morgan N.G. (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52, 1686 1688.
39. Rosenberg L. (1995) In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells. Cell Tranplantation 4, 371 383.
40. Shanmugam M., Reddy M.A., Guha M., Natarajan R. (2003) High glucose-induced expression of proinflammatory cytokine and chemokine genesin monocytic cells. Diabetes 52, 1256 1264.
41. Shimabukuro M., Ohneda M., Lee Y., Unger R. (1997) Role of nitric oxide in obesity-induced β cell disease. J. Clin. Invest. 100, 290 295. (Pubitemid 27349075)
42. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. (1998) Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc. Natl Acad. Sci. USA 95, 2498 2502.
43. Stefan Y., Orci L., Malaisse-Lagae F., Perrelet A., Patel Y., Unger R.H. (1982) Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31, 694 700.
44. G-nitro-l-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology 135, 849 853.
45. Takaishi H., Taniguchi T., Takahashi A., Ishikawa Y., Yokoyama M. (2003) High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem. Biophys. Res. Commun. 305, 122 128.
46. Tokuyama Y., Sturis J., DePaoli A.M. et al. (1995) Evolution of β cell dysfunction in the male Zucker Diabetic Fatty rat. Diabetes 44, 1447 1457.
47. Unger R.H. (2002) Lipotoxic diseases. Annu. Rev. Med. 53, 319 336.
48. Wautier J.L., Guillausseau P.J. (2001) Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. (Paris) 27, 535 542.
49. Zhou Y.-T., Grayburn P., Karim A. et al. (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl Acad. Sci. USA 97, 1784 1789.